The low levels of p27 and p16, coupled with increased CDK activities, are often associated with the tumorigenesis of various cancers, including GBM (Razavipour et al., 2020; Gkikas et al., 2021; Lu et al., 2022). This evidence concerns the gene CDKN2A and glioblastoma.